TopiVert Pharma Limited

HanAll BioPharma Co. Ltd. and Daewoong Pharmaceutical Co. Ltd. have unveiled top-line results from the first US Phase III study for HL036, their investigational biologic for the treatment of dry ey

The news that US regulators have rejected Kala Pharmaceuticals Inc. 's dry eye disease therapy is no great surprise but the company still believes that KPI-121 will be able to make its mark in a pote

Although TopiVert Ltd. 's dry eye disease candidate has failed to hit its primary goal in a late-stage trial, a number of other multiple endpoints were met, giving the UK firm cause for optimism. Top

Novartis AG has entered into an agreement to fully acquire from Takeda Pharmaceutical Co. Ltd. the ex- Shire PLC dry eye drug Xiidra (lifitegrast ophthalmic solution 5%) and related assets, in a